Cytoplasmic FUS aggregates are a pathological hallmark in a subset of patients with frontotemporal dementia (FTD) or amyotrophic lateral sclerosis (ALS). A key step that is disrupted in these patients is nuclear import of FUS mediated by the import receptor Transportin/Karyopherin-b2. In ALS-FUS patients, this is caused by mutations in the nuclear localization signal (NLS) of FUS that weaken Transportin binding. In FTD-FUS patients, Transportin is aggregated, and post-translational arginine methylation, which regulates the FUS-Transportin interaction, is lost. Here, we show that Transportin and arginine methylation have a crucial function beyond nuclear import-namely to suppress RGG/RG-driven phase separation and stress granule association of FUS. ALS-associated FUS-NLS mutations weaken the chaperone activity of Transportin and loss of FUS arginine methylation, as seen in FTD-FUS, promote phase separation, and stress granule partitioning of FUS. Our findings reveal two regulatory mechanisms of liquid-phase homeostasis that are disrupted in FUS-associated neurodegeneration.
INTRODUCTION
Protein aggregates are a pathological hallmark of all neurodegenerative diseases and are thought to drive the process of neurodegeneration (Taylor et al., 2002) . In ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia), the major aggregating proteins are two ubiquitously expressed RNA-binding proteins (RBPs) called TDP-43 (TAR DNA-binding protein of 43 kDa) and FUS (fused in sarcoma) (Neumann et al., 2006 (Neumann et al., , 2009 . TDP-43 and FUS are enriched in the cell nucleus, but in post mortem brains and spinal cords of ALS/FTD patients, they are often absent from the nucleus and are found in cytoplasmic aggregates in neuronal and sometimes glia cells (Mackenzie et al., 2010) . RBP aggregation is thought to cause widespread disturbances in neuronal RNA metabolism and neurodegeneration by loss-and/or gain-of-function mechanisms (Ling et al., 2013) . How cytosolic RBP aggregation arises and which cellular quality control mechanisms help to prevent it are not well understood.
A key pathomechanism in ALS/FTD cases with FUS aggregates is defective nuclear import. Mutations in FUS that cause familial ALS (ALS-FUS) (Kwiatkowski et al., 2009; Vance et al., 2009 ) often alter or entirely delete the C-terminal nuclear localization signal (NLS) and thus impair nuclear import of FUS (Dormann et al., 2010) . The NLS consists of a C-terminal proline tyrosine (PY)-NLS (Lee et al., 2006) and the preceding arginine/ glycine-rich RGG3 domain (Dormann et al., 2012) . Both domains interact with the nuclear import receptor Transportin (TNPO1)/ Karyopherin-b2 (Kapb2) (Lee et al., 2006) , which translocates FUS across the nuclear pore complex into the nucleoplasm. Reduced TNPO1 binding and impaired nuclear import of FUS is pathogenic, as FUS mutations that lead to severely reduced TNPO1 binding cause early ALS onset and rapid disease progression (Dormann et al., 2010) . This phenotype was recently modeled in mice, where FUS-NLS mutations cause motor neuron degeneration (Devoy et al., 2017; Scekic-Zahirovic et al., 2017) .
Defective nuclear import also plays a role in FTD cases with FUS pathology (FTD-FUS), which are usually not associated with FUS mutations (Snowden et al., 2011) . In these cases, TNPO1 is aggregated and partially detergent-insoluble (Brelstaff et al., 2011; Neumann et al., 2012) . Moreover, arginine methylation (arg-methylation), which regulates TNPO1 binding and nuclear import of FUS, is defective in FTD-FUS patients (Dormann et al., 2012; Suá rez-Calvet et al., 2016) . Arg-methylation is a common post-translational modification (PTM) in nuclear RBPs, often regulating their nuclear localization, as well as protein-protein or protein-RNA interactions (Bedford and Clarke, 2009) . Arg-methylation is carried out by protein arginine methyltransferases (PRMTs), which transfer one or two methyl groups from S-adenosyl-methionine (SAM) onto the arginine side chain (Yang and Bedford, 2013) . FUS contains three arginine-glycineglycine (RGG) repeat domains with RGG/RG motifs that are extensively modified with asymmetric dimethyl groups by PRMT1 or PRMT8 (Ong et al., 2004; Scaramuzzino et al., 2013) . We have previously shown that arginine dimethylation is lost in FTD-FUS patients. Instead, deposited FUS is un-or monomethylated (Dormann et al., 2012; Suá rez-Calvet et al., 2016) . However, it is still unclear whether loss of FUS arg-methylation is pathogenic and contributes to FUS dysfunction or aggregation.
We and others have previously proposed that FUS aggregation is initiated in stress granules (SGs), as ALS-associated FUS-NLS mutations cause an accumulation of FUS in SGs, and FUS aggregates in ALS/FTD post mortem brains often contain SG marker proteins (Dormann et al., 2010; Li et al., 2013) . Thus, SGs or other ribonucleoprotein (RNP) granules may act as condensation sites, where aggregation-prone RBPs start to aggregate once they exceed a critical concentration. Recently, it has been shown that FUS and related RBPs undergo concentration-dependent, reversible liquid-liquid phase separation (LLPS) in vitro, i.e., they form liquid-like protein droplets that have similar dynamic properties as cellular RNP compartments. Over time, liquid FUS and hnRNP-A1 droplets undergo an irreversible ''liquid-to-solid phase transition'' and form solid, fibrous aggregates in vitro (Molliex et al., 2015; Patel et al., 2015) . LLPS and liquid-to-solid phase transition of FUS is concentration dependent (Patel et al., 2015) ; hence, the high local concentration of FUS in SGs may promote LLPS and solidification of FUS.
In the case of FUS, LLPS and aggregation are reported to be largely driven by the N-terminal SYGQ-rich domain (Burke et al., 2015; Kato et al., 2012; Murakami et al., 2015; Patel et al., 2015; Sun et al., 2011) , which has a similar amino acid composition as yeast prion domains (King et al., 2012) . Here, we show that the C-terminal RGG3-PY domain and arginines in RGG motifs of FUS are also crucial for phase separation of FUS. We demonstrate that TNPO1, which directly interacts with arginines in the RGG3-PY domain, acts as a FUS chaperone and suppresses phase separation and SG association of FUS. Furthermore, we establish that arg-methylation of FUS reduces LLPS and SG association of FUS, suggesting that loss of argmethylation, as seen in FTD-FUS patients, is pathogenic by directly promoting FUS aggregation. Finally, we show that the ALS-associated FUS-P525L mutation renders the protein less sensitive to the chaperone activity of TNPO1 and thus not only impairs nuclear import, but also enhances phase separation and SG accumulation of mutant FUS. Our findings reveal two novel regulatory mechanisms of liquid phase homeostasis that are disrupted in FUS-associated ALS and FTD. This supports the view that phase separation and SG accumulation of FUS are crucially involved in ALS/FTD pathogenesis.
RESULTS

Transportin Suppresses Phase Transitions of FUS In Vitro
As several Importin b (Impb)-type nuclear import receptors were shown to act as cytoplasmic chaperones of positively charged ribosomal proteins and histones (Jä kel et al., 2002) , we hypothesized that TNPO1 may exert a similar function toward other positively charged import cargoes, including FUS. To test whether TNPO1 affects phase transitions of FUS, we purified MBP-FUS-EGFP-His 6 and MBP-FUS-His 6 (see scheme in Figure S1A) from E. coli. At physiological FUS concentrations, both proteins were soluble and dispersed, whereas proteolytic removal of the MBP-tag with TEV protease caused them to phase separate and form numerous liquid-like droplets (Figures 1A and S1B) . To verify that droplet formation was not induced by TEV protease independently of proteolytic cleavage, we used MBP-FUS containing a PreScission cleavage site, which formed droplets upon addition of PreScission protease, but not upon addition of TEV protease ( Figure S1B ).
To assess how TNPO1 affects LLPS of FUS, we added equimolar amounts of purified TNPO1 or buffer only to MBP-FUS-EGFP and monitored TEV cleavage-induced FUS droplet formation. Strikingly, droplet formation was significantly suppressed by TNPO1 (Figures 1A; see Figure 1B for quantification). Moreover, when TNPO1 was added to preformed FUS droplets, they immediately dissolved ( Figure S1C ), indicating that TNPO1 is able to reverse LLPS of FUS. Two other direct FUS interactors ( Figure S1D ), PRMT1 (Scaramuzzino et al., 2013) and an anti-FUS-RGG3-specific antibody (Suá rez-Calvet et al., 2016) , were unable to suppress FUS droplet formation to the same degree as TNPO1 (Figures 1A and 1B) . Likewise, the nuclear import receptor Importin 5 (Imp5), which is not the cognate importin of FUS and does not bind to FUS in vitro ( Figure S1D ), also did not suppress LLPS of FUS ( Figures 1A and 1B) .
Next, we monitored phase separation of non-EGFP-tagged FUS in a turbidity assay, where the optical density of the protein solution is used as a measure of phase separation. The solution became turbid upon TEV cleavage of MBP-FUS in the presence of buffer, PRMT1, anti-FUS-RGG3 antibody, or Imp5, whereas turbidity remained low in the presence of TNPO1 ( Figure 1C ). Second, we used a sedimentation assay, where samples are centrifuged, and partitioning of FUS into the pellet fraction is used as a measure of phase separation. Upon TEV cleavage, FUS quantitatively entered the pellet fraction but remained mainly in the supernatant when TNPO1 was present ( Figure 1D ; see Figure 1E for quantification). In contrast, PRMT1, the FUS-RGG3-specific antibody, or Imp5 were unable to prevent partitioning of FUS into the pellet fraction.
Finally, we performed in vitro ''aging'' experiments, in which liquid FUS droplets are incubated for a few hours with mild turbidity (600 nm) *** *** *** agitation and thus are converted into large amorphous aggregates over time (Patel et al., 2015) . Addition of TNPO1, but not PRMT1 or Imp5, prevented formation of amorphous FUS-EGFP structures that normally formed during in vitro aging ( Figure 1F) . Similarly, after a 90-min in vitro incubation of TEVcleaved MBP-FUS, transmission electron microscopy (TEM) revealed the presence of rod-like FUS fibrils, which was prevented in the presence of TNPO1 ( Figure 1G ).
Together, these results demonstrate that TNPO1 appears to have a dual function and not only mediates nuclear import of FUS, but also acts as a chaperone and suppresses LLPS and consequent solidification of FUS in vitro.
Transportin Reduces SG Association of FUS, Independent of Its Nuclear Import Activity TNPO1 is expected to exert its chaperone function toward FUS mainly in the cytoplasm, where RanGTP levels are low and TNPO1 binds tightly to PY-NLS-containing cargoes (Lee et al., 2006) . To test whether TNPO1 indeed acts a chaperone of FUS in cells, we expressed a cytosolically anchored version of FUS (GCR 2 -tagRFP 2 -FUS) in HeLa cells. This fusion protein is retained in the cytoplasm by a hormone-responsive domain of the glucocorticoid receptor (GCR) (Love et al., 1998) . We interfered with FUS-TNPO1 binding by co-expressing a peptide inhibitor of TNPO1, EGFP-M9M, which binds TNPO1 with unnaturally high affinity and competes with natural TNPO1 cargoes (Cansizoglu et al., 2007) . As a control, we expressed an Importin a (Impa)-specific high-affinity peptide inhibitor (EGFPbimax) that interferes with Impa-cargo binding and Impa/ b-dependent nuclear import (Kosugi et al., 2008) . In cells expressing bimax, cytosolically anchored FUS remained diffusely distributed, whereas in cells expressing M9M, FUS was localized in TIA1-positive SGs in a significant number of cells (Figures 2A and 2B) . Note that M9M-expressing cells had similar or lower expression levels of GCR 2 -tagRFP 2 -FUS than bimax-expressing cells (data not shown). This suggests that impaired FUS-TNPO1 binding favors partitioning of cytosolic FUS into SGs.
To directly test the hypothesis that TNPO1 suppresses SG association of FUS, we utilized a modified version of the semi-permeabilized cell assay that is routinely used to study nuclear transport of proteins under defined conditions (Adam et al., 1990) . We elicited SGs by treating HeLa cells with the proteasome inhibitor MG132 and then selectively permeabilized the plasma membrane using digitonin and washed out soluble factors, including importins (see scheme in Figure 2C ). To focus only on the cytosolic function of TNPO1, we prevented nuclear import by blocking nuclear pores with wheat germ agglutinin (WGA) (Yoneda et al., 1987) . Upon addition of MBP-FUS-EGFP to semi-permeabilized cells, the protein specifically associated with G3BP1-positive SGs ( Figure 2D ). Consistent with our hypothesis, SG association was significantly reduced when TNPO1 was added together with FUS ( Figures 2D  and 2E) .
In summary, our data show that TNPO1 reduces partitioning of FUS into SGs independent of its nuclear import activity. This demonstrates that TNPO1 not only suppresses phase transitions of FUS in vitro, but also acts as a FUS chaperone in the cytoplasm, thus reducing the risk of aberrant FUS phase transitions in SGs.
C-Terminal RGG/RG Motifs Are Crucial for Phase Separation of FUS FUS contains extended disordered LC domains, including the N-terminal SYGQ-rich domain and C-terminal RGG domains enriched in RGG/RG motifs ( Figure 3A ). Even though LLPS and aggregation of FUS is thought to be largely driven by the N-terminal SYGQ-rich domain (Kato et al., 2012; Patel et al., 2015; Sun et al., 2011) , there is evidence that C-terminal regions, in particular RGG/RG-rich domains, contribute to phase separation and aggregation of FUS (Boeynaems et al., 2017; Schwartz et al., 2013) . As TNPO1 binds to the C-terminal RGG3-PY domain, we speculated that this domain critically contributes to phase separation of FUS and that TNPO1 may achieve chaperoning of FUS by interacting with LLPS-promoting RGG/ RG motifs.
To test this hypothesis, we purified the C-terminal RGG3-PY domain (see Figure S2A for sequence) from E. coli and tested its ability to phase separate. In the presence of substoichiometric amounts of RNA, RGG3-PY formed liquid droplets in a concentration-and temperature-dependent manner (Figures 3B and S2B) , similar to the N-terminal SYGQ-rich domain (Burke et al., 2015) . Formation of RGG3-PY droplets was enhanced at lower salt concentrations ( Figure S2C ), suggesting that electrostatic interactions involving RGG/RG motifs drive LLPS of this domain. To investigate the importance of arginines in LLPS of RGG3-PY, we expressed and purified a mutant version, termed KGG3-PY, in which all arginines in RGG motifs were replaced by lysine (K) (see Figure S2A ). Strikingly, KGG3-PY remained completely dispersed and did not form any visible droplets under conditions Values represent means ± SEM (n = 3). ***p < 0.001 by one-way ANOVA with Dunnett's multiple comparison test. (C) Turbidity assay to quantify phase separation of 7 mM MBP-FUS upon TEV cleavage ± TNPO1, PRMT1, Imp5, or anti-FUS-RGG3 antibody, respectively. Values represent means ± SEM (n = 3). ***p < 0.001 by one-way ANOVA with Dunnett's multiple comparison test. (D) Sedimentation assay to quantify phase separation of MBP-FUS after TEV cleavage ± TNPO1 or control proteins (Imp5, anti-FUS-RGG3 antibody, or PRMT1). (E) Quantification of FUS levels in supernatant (S) and pellet (P) fractions as S/P ratio. Values represent mean ± SEM (n = 3). ***p < 0.001 by one-way ANOVA with Dunnett's multiple comparison test. (F) TNPO1 prevents LLPS and consequent liquid-to-solid phase transition of FUS-EGFP droplets (7 mM) in an in vitro aging assay. Bar, 50 mm. (G) 7 mM MBP-FUS was incubated for 90 min with TEV protease ± TNPO1 and processed for TEM. Arrows indicate fibrillary FUS assemblies formed upon TEV cleavage. Bar, 200 nm. See also Figure S1 .
that induced large RGG3-PY droplets ( Figure 3B ). This demonstrates that arginines in RGG motifs are crucial for LLPS of the RGG3-PY domain.
To test whether the C-terminal RGG3-PY domain and arginine residues in RGG/RG motifs are important for phase separation of full-length FUS, we purified two mutant versions of MBP-FUS where we either deleted the C-terminal RGG3-PY domain (DRGG3-PY) or mutated all arginines in RGG/RG motifs to lysine (all-KGG) (see Figure S2D for western blot characterization). In a turbidity assay, FUS wild-type (FUS-WT) showed a strong turbidity increase, whereas FUS-DRGG3-PY yielded lower turbidity values, and the all-KGG mutant failed to become turbid at all ( Figure 3C ). Sedimentation analysis confirmed that DRGG3-PY shows reduced partitioning into the pellet fraction compared to FUS-WT, and the all-KGG mutant remained mostly soluble ( Figures 3D and 3E ). Thus, phase separation of FUS not only requires the N-terminal SYGQ-rich domain, but also arginine residues in C-terminal RGG/RG motifs. 
Molecular Mechanisms Contributing to Chaperoning of FUS by TNPO1
Based on this finding, we considered two not mutually exclusive hypotheses as to how TNPO1 may suppress LLPS of FUS. First, as RGG/RG motifs were shown to be crucial for RNA binding of FUS (Ozdilek et al., 2017) , we considered the possibility that TNPO1 may compete with RNA binding to RGG/RG motifs and hence suppress RNA-driven LLPS of FUS. Second, TNPO1 may directly interact with arginines and thus interfere with arginine-driven LLPS of FUS.
To address the first hypothesis, we performed nuclear magnetic resonance (NMR) spectroscopy and examined the effect of TNPO1 on RNA-driven phase separation of the RGG3-PY domain. Addition of increasing amounts of unlabeled RNA to 15 N-labeled RGG3-PY caused the sample to become turbid (data not shown) and led to progressive disappearance of 1 H-15 N cross peaks ( Figure S2E ) and decreased signal intensity in the corresponding 1D NMR spectra ( Figure S2F ). This is in agreement with the formation of high-molecular-weight RGG3-PY/RNA droplets, leading to broadening of NMR signals due to the decreased rotational tumbling time of the RGG3 region within droplets. RNA was quantitatively bound by RGG3-PY droplets, as NMR signals of unlabeled RNA were absent in the 1D NMR spectra ( Figure S2F ). Addition of TNPO1 to the RGG3-PY/RNA droplet sample led to reappearance of the RNA 1 H NMR signals ( Figure S2F ) and a loss of turbidity, indicating that TNPO1 binding displaces the RNA from RGG3-PY and results in droplet dissolution. Concordantly, radioactive filter binding experiments demonstrated that RNA is displaced from full-length FUS upon addition of TNPO1 ( Figures 3F and S2G ). However, in the turbidity assay, we did not detect an altered phase separation behavior of full-length FUS upon titrating in ASH1 E3-51 RNA ( Figure 3G ); similar results were obtained for MAPT RNA and total RNA (data not shown). This suggests that phase separation of full-length FUS is not strongly affected by RNA under our experimental conditions. Hence, the displacement of RNA from FUS might not be the major mechanism by which TNPO1 suppresses phase separation of FUS.
In support of the second hypothesis, namely that TNPO1 interferes with phase separation of FUS by interacting with arginines in the C-terminal RGG3-PY domain, we have previously shown that TNPO1 directly binds to a synthetic FUS-RGG3 peptide (Dormann et al., 2012) and to several arginine residues in the FUS-RGG3 region (R472, R473, R476) (Gö bl et al., 2016) . This interaction appears to be mainly charge-driven, as we observed a strong decrease in binding of TNPO1 to RGG3-PY at higher salt concentration ( Figure S4A and Table S1 ). Together, our previously published data and our isothermal titration calorimetry (ITC) results show that electrostatic interactions and arginine residues play a key role in binding of RGG3-PY to TNPO1. As arginine residues and the C-terminal RGG3-PY domain of FUS appear to be crucial for phase separation of FUS ( Figures  3B-3E ), we propose that direct binding of TNPO1 to arginines in the RGG3-PY domain interferes with arginine-driven phase separation of FUS and thus could be an important component of the chaperoning mechanism.
Arginine Methylation Reduces LLPS and SG Association of FUS As arginines in RGG/RG motifs have an important contribution to LLPS of FUS ( Figures 3B-3E ), we asked how arg-methylation alters phase separation of FUS. This question is of great interest, as arg-dimethylation of the FUS-RGG3 domain is lost in FTD-FUS patients (Dormann et al., 2012; Suá rez-Calvet et al., 2016) , but it is unclear whether and how loss of FUS methylation is pathogenic.
To address this question, we in vitro methylated purified MBP-FUS-EGFP, MBP-FUS, or RGG3-PY by adding the purified arginine methyltransferase PRMT1 and SAM as a methyl donor ( Figure S3A ). FUS proteins were purified from bacteria and therefore were originally unmethylated. After incubation with PRMT1 and SAM, all three proteins were efficiently converted from an un-to a dimethylated form but remained unmethylated upon incubation with PRMT1 only ( Figure S3B ; similar results for MBP-FUS and RGG3-PY, data not shown). First, we examined the propensity of unmethylated and methylated MBP-FUS-EGFP to undergo LLPS and found that unmethylated FUS formed liquid droplets at lower concentrations than dimethylated FUS ( Figure 4A ). This difference was not caused by the methyl donor SAM, as addition of SAM alone did not alter droplet formation (data not shown). Compared to dimethylated FUS, unmethylated FUS also showed reduced internal mobility within the dense droplet phase as measured by fluorescence recovery after photobleaching (FRAP) following a ''half bleach'' of FUS-EGFP droplets ( Figures 4B and 4C) . Moreover, in a turbidity assay, unmethylated FUS reached higher turbidity values than methylated FUS ( Figure 4D ). Sedimentation analysis confirmed that unmethylated FUS had a higher propensity to partition into the pellet fraction compared to methylated FUS ( Figures S3C  and S3D ). Enhanced phase separation was also observed for the unmethylated RGG3-PY domain, which reached higher turbidity values than methylated RGG3-PY upon addition of RNA ( Figure S3E ). This difference was not due to altered RNA binding, as filter binding experiments demonstrated equal affinity of unmethylated and methylated RGG3-PY for RNA (Figures S3F and S3G and Table S2 ).
To transfer these findings into cells, we investigated whether arg-methylation affects SG association of FUS in the semi-permeabilized cell assay. Indeed, unmethylated FUS showed a higher association with G3BP1-positive SGs compared to the methylated protein (Figures 4E and 4F) . This suggests that unmethylated FUS associates with SGs more stably than methylated FUS. In conclusion, loss of FUS arg-methylation, as seen in FTD-FUS patients, promotes LLPS and SG partitioning of FUS and thus may contribute to FUS aggregation in FTD-FUS patients.
The ALS-Associated FUS-P525L Mutation Renders FUS Less Sensitive to the Chaperone Activity of TNPO1 Most ALS patients with FUS pathology carry a mutation in the PY-NLS that causes reduced binding to TNPO1 and impairs nuclear import of FUS (Dormann et al., 2010; Zhang and Chook, 2012) . Given our finding that TNPO1 suppresses LLPS and SG association of FUS, we hypothesized that FUS PY-NLS mutations may also impair chaperoning of FUS by TNPO1 and thus promote aberrant phase transitions and SG partitioning of mutant FUS.
To test this hypothesis, we purified MBP-FUS-EGFP and the RGG3-PY domain with an intact or mutant (P525L) PY-NLS. The P525L mutation severely weakens TNPO1 binding (Zhang and Chook, 2012) and causes early-onset ALS and rapid disease progression (Chiò et al., 2009) . As the FUS-RGG3 domain is normally arg-methylated in ALS-FUS patients, and this furthermore weakens TNPO1 binding (Dormann et al., 2012) (Figures S4A  and S4B and Table S1 ), we in vitro methylated WT and mutant proteins ( Figure S4C ) and then examined their ability to phase separate in the presence and absence of TNPO1. Without TNPO1, mutant and WT proteins formed liquid droplets to a similar extent ( Figures 5A and 5B) ; hence, the P525L mutation does not alter LLPS of FUS under these conditions. In line with our hypothesis, the WT protein was efficiently chaperoned by TNPO1, whereas the mutant protein still formed liquid droplets in the presence of TNPO1, even after prolonged incubation (8 hr) (Figures 5A and 5B) .
To test whether the P525L mutation also causes reduced chaperoning by TNPO1 in cells, we examined the ability of See also Figure S3 and Table S2 . See also Figure S4 and Table S1 .
TNPO1 to suppress SG association of WT versus mutant MBP-FUS-EGFP in the semi-permeabilized cell assay. Both WT and mutant proteins showed a similar SG association; however, addition of TNPO1 reduced SG partitioning of the WT protein but was significantly less efficient in chaperoning the P525L mutant protein ( Figures 5C and 5D ). This was not due to better nuclear import of the WT protein, as nuclear pores were blocked in this assay by WGA. Finally, we tested whether the P525L mutation favors SG partitioning of FUS in intact and living cells independent of reduced nuclear import. To do so, we used the GCR-based cytosolic anchoring system and expressed GCR 2 -tagRFP 2 -tagged FUS-WT or P525L in HeLa cells. Both fusion proteins are localized in the cytoplasm ( Figure 5E ) and reached similar expression levels (data not shown). In cells where TIA1-positive SGs were elicited due to transfection stress, the WT protein was predominantly diffusely distributed in the cytoplasm and showed little SG association, whereas the P525L mutant protein frequently co-localized with TIA1-positive SGs (Figures 5E and 5F).
Together, our in vitro and cellular data show that ALS-associated FUS-NLS mutations that strongly reduce TNPO1 binding not only impair nuclear import of FUS, but also render the protein less sensitive to the chaperoning activity of TNPO1. Hence, such mutations have an unexpected novel pathomechanism and favor aberrant phase transitions and SG partitioning of mutant FUS in the cytoplasm.
DISCUSSION
The Nuclear Import Receptor TNPO1 Acts as a Cytoplasmic Chaperone of FUS FUS is among the top 5% of proteins in terms of protein abundance (Wi sniewski et al., 2014) , hence its cellular concentration (2-10 mM) is close to the critical concentration where purified FUS undergoes LLPS and liquid-to-solid phase transition in vitro (Patel et al., 2015) . This suggests that efficient protein quality control (PQC) mechanisms prevent such aberrant phase transitions in cells. Our data demonstrate that TNPO1 fulfills such a PQC function and suppresses aberrant phase transitions of FUS in vitro and in the cytoplasm and decreases the potentially detrimental accumulation of FUS in SGs. SGs are thought to be the sites where FUS (and other aggregation-prone RBPs) get highly concentrated and thus undergo concentrationdependent LLPS and aggregation (Alberti and Hyman, 2016) . The importance of SGs for RBP aggregation is underscored by the observation that FUS and TDP-43 aggregates in ALS and FTD patients contain various SG marker proteins (Bentmann et al., 2012; Dormann et al., 2010) and that ALS-causing mutations in FUS or other RBPs promote SG localization or alter SG dynamics (Kim et al., 2013; Mackenzie et al., 2017) . Our data show that (1) impaired FUS-TNPO1 binding in cells promotes SG localization of FUS and that (2) TNPO1 directly reduces SG partitioning of FUS. This activity of TNPO1 is independent of its nuclear import function, as nuclear import of FUS was blocked in our cellular assays. Interestingly, TNPO1 and other importins are found in SGs and P bodies (Chang and Tarn, 2009 Importins may have a general chaperone function toward aggregation-prone basic proteins, as several other Impb-type nuclear import receptors were shown to prevent aggregation of basic ribosomal proteins and histones (Jä kel et al., 2002) and phenylalanine-glycine (FG)-rich nucleoporins (Milles et al., 2013) . As importins are similarly abundant as heat shock proteins, they appear suited to shield basic stretches on abundant import cargoes, including ALS/FTD-associated RBPs. Indeed, Impa/b prevents and reverses TDP-43 fibrillization, and TNPO1 also inhibits and reverses fibrillization of the PY-NLScontaining cargoes EWS, TAF15, hnRNP-A1, and hnRNP-A2 (Guo et al., 2018) .
Arginines in RGG/RG Motifs Are Crucial for Phase Separation of FUS So far, LLPS and aggregation of FUS were thought to be primarily driven by the N-terminal SYGQ-rich domain (Burke et al., 2015; Kato et al., 2012; Murakami et al., 2015; Patel et al., 2015; Sun et al., 2011) . Our data now show that the C-terminal RGG3-PY domain and, in particular, arginines in RGG/RG motifs also play a crucial role in phase separation of FUS. Our findings are consistent with the previous reports that the RGG2-ZnF-RGG3 domain of FUS forms fibrous assemblies in vitro (Schwartz et al., 2013) and that a synthetic FUS-RGG3 peptide forms droplets in the presence of a molecular crowder or polyU 30 (Boeynaems et al., 2017) . RGG/RG-rich sequences were also shown to drive phase separation of the C. elegans P granule proteins LAF-1 and PGL-3 and the human RNA helicases Ddx4, DDX3X, and EIF4H (Elbaum-Garfinkle et al., 2015; Nott et al., 2015 Nott et al., , 2016 Saha et al., 2016) . Moreover, arginine-rich dipeptide repeat (DPR) proteins derived from expanded C9orf72 hexanucleotide repeats phase separate in vitro (Boeynaems et al., 2017) . In the Ddx4 disordered domain, repeatedly spaced RG/GR and FG/GF dipeptides, suggested to engage in arginine-aromatic (cation-p) interactions, were shown to drive LLPS and droplet formation (Nott et al., 2015) . The RGG3-PY domain contains a similar sequence pattern (Figure S2A) , with multiple RGG, RG/GR motifs, as well as (F/Y)G or G/(F/Y) dipeptides. As tyrosine (Y) residues in the N-terminal SYGQ-rich domain of FUS were shown to drive hydrogel formation (Kato et al., 2012) and to promote phase separation of a poly-SH3 domain (Lin et al., 2017) , it can be speculated that both N-terminal tyrosines and C-terminal arginines crucially contribute to phase separation of FUS and possibly promote LLPS by engaging in tyrosine-arginine (cation-p) interactions.
Multiple Mechanisms May Contribute to the Chaperone Activity of TNPO1 So far, TNPO1 was shown to bind to the FUS-PY-NLS (Zhang and Chook, 2012) and the neighboring RGG3 domain as additional binding epitope (Dormann et al., 2012 , Gö bl et al., 2016 . As arginines in RGG/RG motifs are crucial for efficient phase separation of FUS, we propose that direct TNPO1-arginine interactions contribute to chaperoning of FUS by TNPO1. By directly interacting with arginines, TNPO1 may suppress weak intermolecular interactions of arginines with other residues (e.g., cation-p interactions) that drive LLPS of FUS, thus suppressing arginine-driven phase transitions.
Beyond this arginine shielding mechanism, weak interactions of TNPO1 with other FUS domains (e.g., the N-terminal SYGQrich domain or folded RNA-binding domains [RRM and zincfinger domain]) (Yoshizawa et al., 2018) may also contribute to the chaperoning activity of TNPO1. It can be speculated that TNPO1 not only has the ability to break weak transient intermolecular interactions between FG-rich nucleoporins as it traverses the nuclear pore, but can also engage in multiple low-affinity interactions with different sites of NLS-bound cargo proteins to keep them soluble in the cytoplasm and during transport. TNPO1-binding to different RNA-binding domains could underlie the RNA displacement that we observed upon addition of TNPO1 to FUS. As RNA has been reported to promote LLPS and aggregation of FUS (Burke et al., 2015; Schwartz et al., 2013) , it seems possible that a displacement of RNA by TNPO1 may additionally contribute to the chaperoning mechanism. As we did not find a promoting effect of different types of RNA on phase separation of full-length FUS in our turbidity assay, the exact role of RNA in LLPS and aggregation of FUS needs to be clarified in future studies. Nevertheless, the displacement of RNA from FUS by TNPO1 may have an important function in the cell and ensure that RBPs, such as FUS, are imported in an RNA-free form, thus preventing mRNA reimport into the nucleus. Moreover, it may help to release mRNAs from RBPs for local translation, as reported for the yeast homolog of TNPO1, Kap104p (van den Bogaart et al., 2009).
Arginine Methylation Reduces LLPS and SG Association of FUS
In line with the idea that RGG/RG motifs are crucially involved in phase separation of FUS, we found that arg-methylation of RGG/RG motifs reduces LLPS of FUS and increases droplet dynamics. A similar effect has been reported for the disordered Ddx4 domain and the LC domain of hnRNP-A2 (Nott et al., 2015; Ryan et al., 2018) . Although arg-methylation does not alter the positive net charge, it changes hydrogen bonding and local hydrophobicity of arginines (Fuhrmann et al., 2015) and thus may influence cation-p interactions that drive LLPS. It seems likely that LLPS of many more proteins is influenced by argmethylation, as RGG/RG-rich domains appear to be an important determinant of LLPS, and there are >400 proteins with trior di-RGG or tri-RG motifs in the human proteome, many of which are arg-methylated (Thandapani et al., 2013) . Prominent examples could be the other two members of the FET (FUS, EWS, TAF15) family, EWS and TAF15, which co-aggregate with FUS in FTD-FUS patients (Neumann et al., 2011) and members of the hnRNP-A family, which form pathological aggregates in rare familial forms of ALS or the related disorder multisystem proteinopathy (Kim et al., 2013; Mori et al., 2013) . It will be interesting to see whether arg-methylation is a PTM that generally reduces overly tight interactions between RGG/RG-rich lowcomplexity domains and thus suppresses aberrant LLPS and aggregation of RGG/RG-rich RBPs.
Distinct Pathomechanisms in FTD-FUS and ALS-FUS Promote Phase Separation and SG Localization of FUS
We have previously shown that aggregated FUS is un-and monomethylated in FTD-FUS patients, whereas it carries argdimethyl groups in healthy cells and ALS-FUS patients (Dormann et al., 2012; Suá rez-Calvet et al., 2016) . We now show that loss of FUS methylation promotes LLPS and SG partitioning of FUS, suggesting that the altered FUS methylation pattern is a pathogenic factor that contributes to the formation of FUS aggregates in patients. What remains to be clarified is why TNPO1 is unable to suppress pathological LLPS and aggregation of hypomethylated FUS in FTD-FUS patients. Efficient chaperoning of hypomethylated FUS by TNPO1 would be expected, as un-and monomethylated FUS show a higher TNPO1 binding affinity than dimethylated FUS (Dormann et al., 2012; Suá rez-Calvet et al., 2016) ( Figure S4 and Table S1 ), and LLPS of unmethylated FUS is efficiently suppressed by TNPO1 (this study; Guo et al., 2018; Yoshizawa et al., 2018) . One explanation could be that TNPO1 is aggregated and partially detergent-insoluble in post mortem brains of FTD-FUS patients (Brelstaff et al., 2011; Neumann et al., 2012) and thus is most likely functionally impaired. Cells with TNPO1 aggregates may have reduced TNPO1 activity, causing impaired nuclear import, enhanced LLPS, and SG partitioning of FUS in the cytoplasm. It can be speculated that loss of FUS methylation may be a compensatory mechanism to increase TNPO1 affinity and thus compensate for reduced TNPO1 activity. How TNPO1 becomes aggregated and how FUS methylation is lost in FTD-FUS patients is unknown. Addressing how TNPO1 levels and FUS methylation are normally regulated and how they can be modulated in cells will be important next steps and may lead to novel therapeutic approaches.
In contrast to FTD-FUS, ALS-FUS patients show a normal methylation pattern (Dormann et al., 2012) ; however, they often carry a FUS PY-NLS mutation, which reduces TNPO1 binding and impairs nuclear import of FUS (Dormann et al., 2010; Zhang and Chook, 2012) . Our study, as well as an accompanying study by Guo et al. (2018) , now show that FUS PY-NLS mutations that severely reduce TNPO1 binding, such as P525L and R495X, also reduce the capacity of TNPO1 to act as a chaperone of FUS. Hence, ALS-associated FUS PY-NLS mutations impart a ''double hit'' and drive (1) cytosolic accumulation due to impaired nuclear import and (2) LLPS and aggregation of FUS in the cytoplasm.
Conclusion
Together, our data reveal two novel mechanisms of liquid-phase homeostasis: (1) arginine methylation and (2) TNPO1 binding. They both suppress phase separation and SG partitioning of FUS and are disrupted in FTD-FUS and ALS-FUS, respectively. These findings support the view that phase separation and the accumulation of FUS in SGs crucially contribute to the pathogenesis of FUS-associated ALS and FTD. Interestingly, a similar pathomechanism has recently been suggested to underlie the most frequent genetic cause of ALS/FTD, a hexanucleotide repeat expansion in the C9orf72 gene (Edbauer and Haass, 2016) , in which arginine-rich DPR proteins (poly-PR, poly-GR) were shown to undergo LLPS, bind numerous LC domain-containing proteins, disturb LLPS of LC domain-containing proteins, and alter formation and dynamics of membrane-less organelles, such as SGs and nucleoli (Boeynaems et al., 2017; Lee et al., 2016) . Thus, disturbed phase transitions appear to be a common theme in ALS/FTD and possibly other RBP-linked disorders.
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Bacterial Growth
All bacterial cultures were grown at 37 C under constant shaking (140-160 rpm) in standard lysogeny broth (LB) medium. Before induction of protein expression, cultures were cooled down to the temperature indicated for the respective protein in the section ''Recombinant protein expression and purification.''
METHOD DETAILS
Generation of cDNA constructs pMal-Tev-Flag-FUS-Tev-His 6 was created by cloning PCR amplified N-terminal Flag-tagged and C-terminal Tev-His 6 tagged FUS cDNA into the SalI-HindIII sites of pMal-Tev using primers SalI_flag_F and HindIII_His 6 -Tev-FUS_R. pMal-Tev was created by cloning annealed double stranded oligonucleotides Tev_F and Tev_R (coding for the Tev cleavage site) into the EcoRI-SalI sites of pMal-c.
To generate pMal-Tev-FUS-EGFP-Tev-His 6 , FUS cDNA was PCR amplified from pMal-Tev-Flag-FUS-Tev-His 6 using primers SalI_FUS_F and BamHI_FUS_R, thus introducing a C-terminal BamHI restriction site. EGFP-His 6 with low-complexity linker was cut from synthetic pEX-A2-linker-EGFP-His 6 (IDT) using BamHI and HindIII sites. In a triple ligation, FUS and EGFP-His 6 fragments were cloned into the pMal-Tev backbone derived from pMal-Tev-flag-FUS-Tev-His 6 .
pMal-Tev-FUS (P525L)-EGFP-Tev-His 6 was generated by site directed mutagenesis of pMal-Tev-FUS-EGFP-Tev-His 6 using primers FUS wt-EGFP mut P525L_F and FUS wt-EGFP mut P525L_R.
To generate pMal-C2-Tev, the C terminus of MBP including parts of the MCS was PCR-amplified (MBP_NcoI_F; MBPLinker_Tev_ EcoRI) introducing a Tev-cleavage site in the reverse primer and replacing the factor Xa cleavage site in the original pMal-C2 (NEB) vector.
pMal-C2-Tev-Flag-FUS DRGG3-PY-Tev-His 6 was generated by cloning PCR amplified N-terminal Flag-tagged and C-terminal Tev-His 6 tagged FUS cDNA encoding amino acids 1-453 into the SalI-HindIII sites of pMal-C2-Tev using primers SalI_flag_F and HindIII_FUS453X-Tev-His 6 _R.
To generate pMal-C2-Tev-Flag-FUS-all-KGG-Tev-His 6 , FUS cDNA was PCR amplified from a synthetic plasmid with all RGGs mutated to KGGs using primers XhoI_FUS_F and HindIII_Tev-His 6 --FUS_R and cloned into the pMal-C2-TEV backbone derived from pMal-C2-Tev-Flag-FUS DRGG3-PY-Tev-His 6 . petM11-His 6 -ZZ-Tev-FUS-KGG3-PY was generated by cloning FUS cDNA encoding amino acids 454-526 from a synthetic plasmid with all RGGs mutated to KGGs using primers FUS 454_NcoI_F and BamHI_FUS_R and cloned into the petM11-His 6 -ZZ backbone derived from petM11-His 6 -ZZ-Tev-FUS-RGG3-PY.
To generate pETM11-His 6 -ZZ-Tev-TNPO1, the human TNPO1 cDNA sequence was codon optimized for protein production in bacterial cells and flanked by NcoI and BamHI restriction sites (Genscript). The coding region was cloned into a modified pETM11 bacterial expression vector, which includes an N-terminal His 6 , protein A (ZZ) tag and a TEV protease cleavage site.
To generate GCR 2 -tagRFP 2 -FUS, the EGFP 2 -sequence in a modified EGFP-C1 vector containing a GCR 2 -EGFP 2 -cassette (Hutten et al., 2008) was replaced sequentially with a two cDNAs coding for tagRFP (primer: TagRFP_AgeI/TagRFP_EcoRV and TagRFP_Spe/ TagRFP_AgeI_R). FUS wt or P525L was inserted via EcoRV/BamHI sites replacing the NLS sequence (primer: FUS_ EcoRV_f with either FUS_BamHI_R or FusP525L_BamHIr).
The pRSV-EGFP-M9M construct was generated by replacing the CMV-promoter in pEGFP-M9M (Dormann et al., 2010) by a RSV promoter sequence (gift from M. Kiebler) via AseI/NheI.
Recombinant protein expression and purification
For expression of recombinant MBP-FUS-His 6 (WT, DRGG3-PY, and all-KGG) and MBP-FUS-EGFP-His 6 (WT and P525L), the respective bacterial expression vectors were transformed into E. coli BL21-DE3-RIPL and BL21-DE3-Rosetta-LysS, respectively, and grown in standard lysogeny broth (LB) medium. At an OD (600 nm) of 0.8, cells were induced with 0.1 mM IPTG for 22 h at 12 C. Cells were lysed in resuspension buffer (50 mM Na 2 HPO 4 /NaH 2 PO 4 , pH 8.0, 300 mM NaCl, 10 mM ZnCl 2 , 40 mM imidazole, 4 mM bME) + 10% glycerol and tandem-affinity purification using HisTrap FF columns (GE Healthcare) and amylose resin (NEB) was performed. The protein was washed with resuspension buffer and eluted in resuspension buffer including 250 mM imidazole and 20 mM maltose, respectively.
For expression of recombinant His 6 -Tev, E. coli BL21-Ros-LysS were transformed with the expression plasmid and grown in standard LB medium. Induction of expression was induced at OD (600 nm) of 0.6 with 1mM IPTG overnight at 20 C. Cells were lysed in lysis buffer (50 mM Tris pH8, 200 mM NaCl, 20 mM imidazole, 10% glycerol, 4 mM b-mercaptoethanol, 1 mg/ml each of aprotinin, leupeptin and pepstatin) by addition of lysozyme and sonification. The lysate was incubated in the presence of RNase A (0.1mg/ml final concentration) for 30min at RT. His-Tev was purified using Ni-NTA beads and washed using lysis buffer containing 1M NaCl. His 6 -Tev was eluted in lysis buffer (pH 8.5) containing 800mM imidazole and dialyzed against storage buffer (20mM Tris pH 7.4; 150mM NaCl; 20% glyercole, 2mM DTT).
For expression of the RGG3-PY domain, pETM11-His 6 -ZZ-FUS-RGG3-PY (WT and KGG3-PY) were transformed into E. coli BL21-DE3 Rosetta and were expressed at 37 C for 4 h. Cells in resuspension buffer were lysed by boiling for 20 min at 90 C, as boiling lysis allows removal of folded proteins from cell lysates, while intrinsically disordered proteins stay soluble (Livernois et al., 2009) . His 6 -ZZ tagged proteins were bound to nickel-nitrilotiacetic (Ni-NTA) resin (QIAGEN), incubated with Benzonase Nuclease (Sigma) overnight at 4 C in Benzonase buffer (50 mM Na 2 HPO 4 /NaH 2 PO 4 , pH 8.0, 50 mM NaCl, 2 mM MgCl 2 ) and subjected to high salt washes with resuspension buffer containing 2 M NaCl and then eluted in resuspension buffer + 250 mM imidazole. In order to proteolytically remove the His 6 -ZZ tag, His 6 -TEV protease (2.5 mg) was added to eluted His 6-ZZ-RGG3-PY proteins and dialyzed against TEV cleavage buffer (20 mM Na 2 HPO 4 /NaH 2 PO 4 , pH 8.1, 150 mM NaCl, 5% glycerol, 4 mM bME) overnight at 4 C. His 6 -TEV and His 6 -ZZ tag were removed by incubation with Ni-NTA resin (QIAGEN), while untagged RGG3-PY remains in the supernatant.
For ITC or NMR experiments, pETM11-His 6 -ZZ-FUS-RGG3-PY (WT or P525L) were transformed into E. coli BL21-DE3 Star strain. For the unlabeled protein, cells were grown for 1 day at 37 C in standard lysogeny broth (LB) medium. At an OD (600 nm) of 0. C. Cell pellets were harvested and sonicated in denaturing buffer containing 50mM Tris-HCl pH 7.5, 150 mM NaCl, 20 mM imidazole, 2 mM tris(2-carboxyethyl)phosphine (TCEP), 20% glycerol and 6M urea. His 6 -ZZ proteins were purified using Ni-NTA agarose (QIAGEN) and eluted in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 200 mM imidazole, 2 mM TCEP and subjected to TEV treatment. Untagged proteins were then isolated performing a second affinity purification using Ni-NTA beads. A final exclusion chromatography purification step was performed in the buffer of interest on a gel filtration column (Superdex peptide, GE Healthcare).
For expression of recombinant His 6 -TNPO1, the bacterial expression vector pETM11-His 6 -ZZ-Tev-TNPO1 was transformed into E. coli BL21-DE3 Star cells. Expression cultures of 1 l volume were grown for 2 days in minimal medium (100 mM KH 2 PO 4 , 50 mM K 2 HPO 4 , 60 mM Na 2 HPO 4 , 14 mM K 2 SO 4 , 5 mM MgCl 2 ; pH 7.2 adjusted with HCl and NaOH with 0.1 dilution of trace element solution (41 mM CaCl 2 , 22 mM FeSO 4 , 6 mM MnCl 2 , 3 mM CoCl 2 , 1 mM ZnSO 4 , 0.1 mM CuCl 2 , 0.2 mM (NH 4 ) 6 Mo 7 O 24 , 17 mM EDTA) supplemented with 6 g of glucose and 3 g of NH 4 Cl. Cells were diluted to an OD (600 nm) of 0.8 and induced with 0.5 mM IPTG followed by protein expression for 4 h at room temperature. His 6 -TNPO1 was purified using Ni-NTA agarose (QIAGEN) and eluted in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 200 mM imidazole, 2 mM TCEP. A final size exclusion chromatography step was performed in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 20 mM imidazole, 2 mM TCEP, 20% glycerol on a gel filtration column (Hiload 16/600 Superdex 200 pg, GE Healthcare). Note, that for ITC/NMR experiments, the His-tag was removed by TEV cleavage.
For expression of recombinant His 6 -PRMT1, the pET28b-PRMT1 vector was transformed into E. coli BL21-DE3 Star and 1 l expression culture was grown in LB medium. Cells were induced at an OD (600 nm) of 0.8 with 0.5 mM IPTG followed by protein expression for 16 h at 20 C. Cell pellets were harvested and sonicated in 50mM Tris-HCl pH 7.5, 150 mM NaCl, 20 mM imidazole, 2 mM TCEP, 20% glycerol. His 6 -PRMT1 was purified using 5 mL HisTrap HP column (GE Healthcare), eluted in 50 mM Tris-HCl pH 7.5, 1 M NaCl, 500 mM imidazole, 2 mM TCEP and further purified by size exclusion chromatography as described for TNPO1 above.
Protein concentrations were determined from their absorbance at 280 nm using ε predicted by the ProtParam tool. For all assay that involved addition of RNA, 260/280 nm ratios of purified proteins were between 0.6 and 0.8.
In vitro methylation FUS proteins and PRMT1 were dialyzed against in vitro methylation (IVM) buffer containing 20 mM Na 2 HPO 4 /NaH 2 PO 4 , pH 8.1, 150 mM NaCl, 5% glycerol, 1 mM EDTA, 1 mM DTT or 50 mM Na 2 HPO 4 /NaH 2 PO 4 , pH 8.0, 150 mM NaCl, 2 mM TCEP for ITC and NMR experiments. FUS proteins were in vitro methylated by incubating with PRMT1 and 1 mM S-adenosyl-L-methionine (SAM) overnight at room temperature. PRMT1 was used at a molar ratio of 2:1 for MBP-FUS, 1.5:1 for RGG3-PY or KGG3-PY (used in droplet and turbidity assays) and 0.2:1 for RGG-PY proteins used in ITC or NMR experiments. For RGG3-PY proteins, PRMT1 was removed by boiling the samples for 10 min at 90 C.
In vitro transcription MAPT RNA and ASH1 E3-51 RNA were produced by in vitro transcription (MEGAshortscript Kit; Ambion) using linearized pGM3 mTauI9-28560 or primers P45 and P132, respectively. For filter binding assays the ASH1 RNA was radioactively labeled using [g32P]ATP and T4 polynucleotide kinase (NEB). The RNA was separated from free nucleotides using NucAway spin columns (Ambion).
In vitro phase separation assays Droplet assay for microscopy Purified RGG3-PY or KGG3-PY and His 6 -TNPO1 were buffer exchanged to droplet buffer (20 mM Na 2 HPO 4 /NaH 2 PO 4 , pH 7.5, 75 mM NaCl, 2.5% glycerol, 1 mM DTT) and concentrated in Amicon Ultra Centrifugal Filter Devices (Millipore). For droplet formation of C-terminal RGG3-PY proteins, proteins were diluted to indicated concentrations and supplemented with in vitro transcribed MAPT RNA (a known FUS target RNA, Orozco et al., 2012) at a molar ratio of 1:50, as this ratio was found to maximally promote phase separation. His 6 -TNPO1, His 6 -Importin 5, aFUS RGG3, or His 6 -PRMT1, respectively, were used at equimolar concentrations to FUS.
Purified full-length MBP-FUS-EGFP (WT or P525L) or MBP-FUS were diluted in droplet buffer including 150 mM NaCl, if not otherwise stated in the figure legend. Full-length FUS was only supplemented with RNA when explicitly mentioned in the figure legend ( Figure 3G ). Phase separation was induced by addition of acTEV protease (Invitrogen) at 25 C. With the exception of Figure 4A , where widefield fluorescence microscopy was applied, imaging of EGFP-tagged FUS was performed by confocal microscopy. Non-fluorescent FUS-droplets were imaged by phase contrast microscopy.
Note that phase separation properties, i.e., critical concentration for droplet formation, differ slightly between different protein preparations. In vitro aging assay To induce aging of FUS-EGFP droplets, TEV-cleaved samples were subjected to 700 rpm on an orbital shaker at RT for 8h and additionally mixed by pipetting up and down every hour. Samples were imaged in 384-well plates by confocal microscopy. Turbidity assay Phase separation of RGG3-PY and MBP-FUS in the absence or presence of equimolar amounts of His 6 -TNPO1, His 6 -Importin 5, aFUS RGG3, or His 6 -PRMT1, respectively, was induced as described above for the droplet assay. Turbidity measurements were conducted at 600 nm in 384-well plates with 20 ml samples using a BioTek Power Wave HT plate reader. All experiments were performed in triplicate.
Sedimentation assay
For sedimentation analysis of full-length FUS, the MBP-tag of 1 mM purified MBP-Flag-FUS protein in the absence or presence of equimolar amounts of His 6 -TNPO1, His 6 -Importin 5, aFUS RGG3, or His 6 -PRMT1, respectively, was cleaved using 0.1 mg/ml His 6 -TEV in 50 ml reaction buffer (50 mM Tris pH 8, 0.5 mM EDTA, 1 mM DTT) for 60 min at 30 C, followed by centrifugation at room temperature for 15 min at 16,000-20,000 g. Equal volumes of supernatant and pellet fraction were analyzed by SDS-PAGE and either SyproRuby stain ( Figures 3D and S3C ) or Western Blot with a FUS-specific antibody (4H11) ( Figure 1D ).
Semi-permeabilized cell assay
HeLa P4 cells were grown on poly-L-lysine coated 12 mm coverslips, permeabilized with 0.003%-0.005% digitonin in KPB (20 mM potassium phosphate pH 7.4, 250 mM sucrose, 5 mM Mg(OAc) 2 , 200 mM KOAc, 1 mM EGTA, 2 mM DTT and 1mg/ml each aprotinin, pepstatin and leupeptin). After several washes to remove soluble proteins (4 3 4 min in KPB on ice), nuclear pores were blocked by 15 min incubation with 200 mg/ml wheat germ agglutinin (WGA) on ice. Cells were then incubated for 30 minutes at room temperature with 125 nM MBP-FUS-EGFP in the absence or presence of 1.25 mM His 6 -TNPO1 in KPB. Note that a 10-fold excess of TNPO1 was required for efficient shielding of FUS, possibly due to other RBPs present in SGs that bind to TNPO1. Subsequently, cells were washed (3 3 5 min in KPB on ice) to remove unbound MBP-FUS-EGFP. SGs were visualized by immunostaining of G3BP1. Note that G3BP1 immunostaining also served as a control for proper permeabilization, as non/poorly-permeabilized cells still show diffuse cytoplasmic G3BP1 staining. Cells were imaged by confocal microscopy using identical settings for reactions within the same experiment.
Filter binding assay
The indicated protein concentrations were incubated with 0.5 nM of in vitro transcribed, radiolabeled ASH1 E3-51 RNA in a total volume of 80 mL in filter-binding buffer (20 mM Na phosphate, 50 mM NaCl, 2 mM DTT, pH 7.5). Samples were applied to nitrocellulose and nylon membranes, using a Dot Blot Aparatus (BioRad), and washed twice with 80 ml filter-binding buffer. Membranes were air-dried and analyzed by phosphorimaging using a Fujifilm FLA-3000 scanner.
Immunocytochemistry Cells grown on coverslips were either fixed 20 h after transfection or after the semi-permeabilized cell assay in 3.7% formaldehyde/ PBS buffer for 7-10 min at RT and permeabilized in 0.5% TX-100/ PBS for 5 min at room temperature. Cells were blocked for 10 min in blocking buffer (1% donkey serum in PBS/ 0.1% Tween-20) and incubated with primary antibodies in blocking buffer for 1-2h at RT or overnight at 4 C. Secondary antibodies were diluted in blocking buffer and incubated for 1h at room temperature. Washing steps after antibody incubation were performed with PBS/0.1% Tween-20. DNA was stained with DAPI at 0.5 mg/ml in PBS and cells mounted in ProLong Diamond Antifade. Imaging was performed by confocal microscopy.
Microscopy
Phase contrast and wide-field fluorescence microscopy For imaging of FUS droplets, samples were placed in sealed sample chambers formed by a hole punched into a double-sided sticky tape, taped onto a glass slide and sealed with a coverslip.
For imaging of RGG3-PY and FUS droplets by phase contrast microscopy, a 63x/1.40 Oil/Ph3 objective was used; FUS-EGFP droplets in Figure 4A were imaged by fluorescence microscopy using a 63x/1.40 Oil objective, both on an Axio Oberver.Z1 wide-field fluorescence microscope and an AxioCam 506 (Zeiss, Oberkochen, Germany).
Confocal microscopy
Confocal microscopy was performed at the Bioimaging core facility of the Biomedical Center with an inverted Leica SP8 microscope, equipped with lasers for 405, 488, 552 and 638 nm excitation. Images were acquired using two-fold frame averaging with a 63x1.4 oil objective, and an image pixel size of 71 nm or 59 nm for droplets and cells, respectively. The following fluorescence settings were used for detection: DAPI: 419-442 nm, GFP: 498-533 nm, RFP/Alexa 555: 562-598 nm, Alexa 647: 650-700 nm. If applicable, recording was performed sequentially to avoid bleed-through using a conventional photomultiplier tube. FRAP In contrast to all other experiments in this study, droplet buffer including 75 mM NaCl was supplemented with 150 mg/ml Ficoll 400 in order to obtain droplets of similar size and shape for FRAP experiments. Experiments were performed on an inverted microscope (Axio Observer.Z1; Carl Zeiss, Oberkochen, Germany) equipped with a confocal spinning disk unit (CSU-X1; Yokogawa, Tokyo, Japan) and a Zeiss 100x/1.46 Oil Ph3 oil immersion lens. Images were acquired in the streaming mode using the 488 nm SD laser line and fixed exposure times of 50 ms and an EM-CCD camera (EvolveDelta; Photomoetrics) at bin 1x1. For localized photobleaching (''half-bleach''), a laser scanning device (UGA-42 Geo; Rapp OptoElectronic, Hamburg, Germany) was used. The ''Geo'' module allowed for simultaneous laser illumination within hardware-defined shapes of different sizes. Here, a square-like shape with an illumination size of 4 mm in the sample was selected. For each experiment, half of the observed structure was bleached to approximately 50% of the initial intensity using a 473 nm diode laser (DL-473/75; Rapp OptoElectronic, Hamburg, Germany). Transmission electron microscopy (TEM) Carbon coated copper grids (carbon film coated 400 mesh copper grids, Science Services) were glow discharged for 2 min in a Harrick plasma cleaner (PDC-32G-2) to facilitate protein adsorption. MBP-FUS (7 mM) -/+ TNPO1 (7 mM) was incubated with TEV protease for 90 min and subsequently diluted to 2 mM and deposited on the grid surface. The grid was washed twice in a drop of double distilled water, blotted shortly using filter paper. Fixing the grid by inverse forceps, 3 ml of 1% uranyl acetate were added to the grid for 30 s. After blotting, the grid was air-dried for at least 30 min. Mosaics of three by three images were obtained at a magnification of 60.000 using a JEOL JEM 1400-plus electron microscope at 120 kV (TEM Center software, JEOL). The Sight X Viewer (JEOL) and ImageJ (NIH) Software packages were applied for mosaic stitching.
Nuclear magnetic resonance
All proteins / RNA samples were prepared in 20 mM Na 2 HPO 4 /NaH 2 PO 4 pH 7.5, 75 mM NaCl, 2.5% glycerol, 1 mM DTT and 10% 2 H 2 O added for the lock signal. NMR experiments were performed at 25 C on Bruker 700 MHz spectrometer. Spectra were processed using Topspin 3.5 and Mnova 11.
Isothermal Calorimetry
All protein samples were prepared either in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl and 2 mM tris(2-carboxyethyl)phosphine (TCEP) or in 50 mM Tris-HCl (pH 7.5), 1 M NaCl and 2 mM TCEP. ITC measurements were carried out on a MicroCal VP-ITC instrument (Microcal, Northhampton, USA) with 36 rounds of 8 mL injections at 25 C. Integration of peaks corresponding to each injection, subtraction of the contribution of protein dilution and correction for the baseline were performed using the Origin-based 7.0 software provided by the manufacturer. Curve fitting was done with a standard one-site model and gives the equilibrium binding constant (Ka), and enthalpy of the complex formation (DH).
QUANTIFICATION AND STATISTICAL ANALYSIS Statistics
Statistical analyses were performed in GraphPad Prism 5. For 2-grouped analyses, for which control and treatment groups were handled in parallel, a paired t test was applied. If measurements were not normally distributed, a non-parametric test (Mann-Whitney) was chosen. 1-way ANOVAs were applied to multi-group comparisons. Here, a Bonferroni post-test was applied when significance between all groups was analyzed, whereas a Dunnett's multiple comparison test was applied when the significance of all values to a single condition was analyzed.
Image analysis
Confocal images were acquired using LAS X (Leica), all other images were acquired in ZEN2 (Zeiss). For illustration of FRAP of FUS-EGFP droplets, images were displayed as heatmap and processed using the interpolation function in ZEN2. All other images were processed using ImageJ/Fiji software applying linear enhancement for brightness and contrast. For quantitative measurements, equal exposure times and processing conditions for respective channels were applied to all samples within one experiment. For better visibility, in some figures the individual channels were displayed in artificial colors as indicated in the figure legends. Droplet quantification Confocal images were imported in the public-domain software ImageJ/Fiji (Schindelin et al., 2012) and a Median filter with radius 2 was applied. Huang auto threshold method providing best coverage of the droplet area was applied. Structures touching the edge of the image section and/or smaller than 0.5 mm 2 were excluded from particle analysis. If required, a watershed analysis was performed.
Quantification of MBP-FUS-EGFP in SGs
For quantitative measurements, equal exposure times and processing conditions for respective channels were applied to all samples within one experiment. In ImageJ/Fiji, ROIs corresponding to SGs were identified using the wand tool by G3BP1 staining and mean fluorescence intensity in the EGFP channel was determined. For each condition, at least 10 cells and at least 28 SGs were analyzed. For display of fluorescence intensity of FUS in SGs, measured fluorescence values were log transformed to achieve a more balanced spread. Statistical analyses were performed in GraphPad Prism 5. Quantification of filter-binding assays Membranes from filter-binding assays were scanned by a FujiFilm FLA-3000 imaging machine. Quantification of signal intensities was carried out using the Dot Blot Analyzer macro within the ImageJ software. For binding experiments, the raw intensities of the individual dots on the nitrocellulose membrane were normalized against the raw intensity measured for the highest FUS concentration. For outcompetition experiments, a ratio of the intensity on the nitrocellulose membrane versus the intensity on nitrocellulose and nylon membrane was determined. The obtained relative intensities were plotted against the protein concentration and fitted using the non-linear curve-fitting tool in Origin software.
FRAP analysis
Intensities of bleached areas were corrected both for bleaching due to imaging over time and background noise. The corresponding calculations were performed with the FIJI/ImageJ macro ''TimeSeries Analyzer'' by calculating the fluorescence intensity over time (I(t)) as follows:
IðtÞ = ½ROI1ðtÞ--ROI3ðtÞ=½ROI2ðtÞ--ROI3ðtÞ
with ROI1 giving the averaged gray values of the bleached area, and ROI2 corresponds to the averaged gray values of the total droplet. ROI3 corresponded to the averaged background values. Obtained values were further normalized to the initial fluorescence by dividing I(t) by the mean gray value of the initial 4 time steps before bleaching < I(1-4)>.
Densitometry measurements
To determine the solubility of FUS by sedimentation analysis of TEV-cleaved MBP-FUS, densitometry measurements of band intensities after Sypro-Ruby staining or FUS immunoblotting of supernatant and pellet fractions, respectively, were performed using standard plugins in the ImageJ software. 
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